Abstract:Objective: Disruption of B cell homeostasis and subsequent dominance of effector B cell subsets are critical for the development of systemic lupus erythematosus (SLE). Revealing the key intrinsic regulators involved in the homeostatic control of B cells has important therapeutic value for SLE. This study was undertaken to determine the regulatory role of the transcription factor Pbx1 in B cell homeostasis and lupus pathogenesis. Methods: We constructed mice with B cell-specific deletion of Pbx1. T cell-dependent and T cell-independent humoral responses were induced by intraperitoneal injection of nitrophenyl-containing hapten (NP) conjugated to keyhole limpet hemocyanin or NP-Ficoll. The regulatory effects of Pbx1 on autoimmunity were observed in a Bm12-induced lupus murine model. We investigated mechanisms of Pbx1 using RNA sequencing, the cleavage under targets and tagmentation assay, and chromatin immunoprecipitation-quantitative polymerase chain reaction assay. We transduced B cells from SLE patients with plasmids that overexpressed PBX1 to explore the in vitro therapeutic efficacy of PBX1. Results: Pbx1 was specifically down-regulated in autoimmune B cells and negatively correlated with disease activity. The deficiency of Pbx1 in B cells resulted in excessive humoral responses following immunization. In the Bm12-induced lupus model, mice with B cell-specific Pbx1 deficiency displayed enhancements in germinal center responses, plasma cell differentiation, and autoantibody production. Pbx1-deficient B cells had increased survival and proliferative advantages after activation. Pbx1 regulated genetic programs by directly targeting critical components of the proliferation and apoptosis pathways. In SLE patients, PBX1 expression was negatively correlated with effector B cell expansion; when PBX1 expression was enforced, the survival and proliferative capacity of SLE B cells were attenuated. Conclusion: Our study reveals the regulatory function and mechanism of Pbx1 in adjusting B cell homeostasis and highlights Pbx1 as a therapeutic target in SLE.

Integrin ITGAM/CD11b Negatively Regulates BCR Signaling to Maintain Autoreactive B Cell Tolerance (P4062)

Integrin CD11b negatively regulates BCR signalling to maintain autoreactive B cell tolerance

Aberrant CD200/CD200R1 Expression and Function in Systemic Lupus Erythematosus Contributes to Abnormal T-cell Responsiveness and Dendritic Cell Activity

Aberrant CD40-Induced NF-κB Activation in Human Lupus B Lymphocytes

Decreased CD1d level is associated with CD86 over-expression in B cells from systemic lupus erythematosus.

CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus

Title: T-bet CD11c B cells are critical for anti-chromatin IgG production in the development of lupus Running title: T-bet regulates CD11c B cells autoantibody production Authors:

T-bet + CD11c + B cells are critical for anti-chromatin IgG production in the development of lupus

T-bet+CD11c+ B Cells Are Critical for Antichromatin Immunoglobulin G Production in the Development of Lupus

Excessive CD11c+Tbet+ B Cells Promote Aberrant TFH Differentiation and Affinity-Based Germinal Center Selection in Lupus.

B cell-intrinsic IFN-γ promotes excessive CD11c+ age-associated B cell differentiation and compromised germinal center selection in lupus mice

B Cells Regulate Thymic CD8+T Cell Differentiation in Lupus-Prone Mice.

Dysregulation of type I IFN and IL-4R signaling regulates the development of BCR VH and VL repertoire encoding anti-Sm autoantibodies in SLE

FcγRIIB-mediated dissociation of BCR-CD19 microclusters and hyperreactivity of lupus B cells (HUM7P.303)

Tlr9-Induced Mir-155 And Ets-1 Decrease Expression Of Cd1d On B Cells In Sle

CTLA-4 expression by B-1a B cells is essential for immune tolerance

Involvement of Transcriptional Factor Pbx1 in Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity

Integrin αvβ3 Limits Cytokine Production by Plasmacytoid Dendritic Cells and Restricts TLR-Driven Autoimmunity

B cell autophagy mediates TLR7-dependent autoimmunity and inflammation

Aberrant High Expression of B Lymphocyte Chemokine (blc/cxcl13) by C11b+Cd11c+ Dendritic Cells in Murine Lupus and Preferential Chemotaxis of B1 Cells Towards Blc

BCL-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.